Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. - Wikidata - awgldk - TriplyDB

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia.

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia.

http://www.wikidata.org/entity/Q45875846

about

Hereditary angioedema: beyond international consensus - circa December 2010 - The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie Lecture Care models in the management of haemophilia: a systematic review NHF-McMaster Guideline on Care Models for Haemophilia Management.Canadian hereditary angioedema guideline.First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from th The national haemophilia program standards, evaluation and oversight systems in the United States of America 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.Public health surveillance and data collection: general principles and impact on hemophilia care.Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance.Home management of haemophilia.A public health approach to the prevention of inhibitors in hemophilia.Public health surveillance of nonmalignant blood disorders.A study of prospective surveillance for inhibitors among persons with haemophilia in the United States.Comprehensive care for haemophilia around the world.Optimal haemophilia care versus the reality.Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia Racial disparity in placental pathology in the collaborative perinatal project The natural evolution of haemophilia care: developing and sustaining comprehensive care globally.A practical approach to hemophilia care in children.Septic arthritis in males with haemophilia.Medical co-morbidities and practice.New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins.Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries.Penny wise, pound foolish: an assessment of Canadian Hemophilia/inherited bleeding disorder comprehensive care program services and resources.The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction.US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization.Optimization of home treatment in haemophilia: effects of transmural support by a haemophilia nurse on adherence and quality of life.Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres.A haemophilia treatment centre-administered disease management programme in patients with bleeding disorders.Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.Linking the world with training and research for improving haemophilia care.Guidelines for the management of hemophilia.Haemophilia in a real-world setting: the value of clinical experience in data collection.A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders.Gene therapy in hemophilia A: a cost-effectiveness analysis

P2860

Q28742240-CCE5D81D-8736-450A-8977-B980D618FFA8 Q30249304-EC16C90A-01BF-471B-8D44-8F6B88753B53 Q30249305-0C8B54F3-F2FA-4F85-9B53-BE888174C9BF Q30596332-92B089F7-4183-4A28-9394-5BC5C1564C11 Q30832356-E7365B37-EF0D-4EBE-A23A-13F191EB62FA Q31115372-CF150216-2126-47B3-B19E-D8D2AC4967C2 Q33708891-8EEB8FDF-A3F7-4272-9B97-0C30E1467767 Q34064761-CB40A72B-92B1-4C99-A4CB-2763BBBD8500 Q34129239-2CABEFC4-7A9A-4547-B2EE-672AB57DDF3A Q34234548-D5C1D42A-97C3-4B96-BCF2-3DB68FF1E0D1 Q35168244-073F5946-36E3-4262-B273-B12D71909CBB Q35666730-D3C3D08C-4193-4B25-9758-B7F423E4EAC9 Q35747998-44251757-67A5-4AEF-8B0A-E4FD2C597D2E Q35794806-36E1D2BF-4E10-4438-AC7B-93E280B6CD91 Q35902290-0BC00967-8130-4DFF-A95B-55C06064C9ED Q35915629-0E4E7504-B7C9-467F-B0F7-62AF3B040678 Q36399847-56F55FFA-F400-4305-81D1-A16734C34CB4 Q36461559-F7EBF417-3EF4-4154-A32A-BA717AE76F42 Q36464790-95C3CB1E-8927-43A3-B075-4A9C64907D65 Q36473025-70B635B6-10F5-47EF-B1B7-AF3BDC7F7E64 Q36860699-695397BD-FF42-45FE-90E4-EEEB592C1883 Q37634189-2194F8FF-68C5-43B6-BB49-BF798F1CAC07 Q38206862-58A31296-20D3-42C4-9722-A99F59BA445B Q38574414-C2871FDF-9889-4D8F-8165-E92C9E1B5059 Q38739036-21693AC9-5894-4F11-B5F0-4A50A26F3C59 Q39952495-19B86F73-3396-4B7D-A4FA-98F1DC64C2FF Q40176037-4BF338A0-024E-444A-AA68-1A5A7B1A57E1 Q40375335-BD0EFF73-5438-4C7A-8F6F-0E3A88DC2FE6 Q43662496-D8B720C4-6AD4-48E9-83EA-102A106E85B8 Q45861239-DB6330BC-E16A-4F87-9792-E515B6A35AAC Q45869765-8283C062-EF83-42DE-8A53-005113A63ED3 Q45871210-25FF2A10-8347-4858-A9AB-5A1B591974C0 Q45874642-47F77E56-01DE-4C50-87E0-A788AFA61F23 Q45877940-4D9BF96A-879E-4876-9B27-14A29FDF98D5 Q45880345-D4B9AAC8-6FCD-4727-89A1-1204A18C3797 Q45882636-BEB00486-1012-43E9-9DC2-FDC02424E0C1 Q52993052-E67B9D37-08A9-4D24-9BCD-04785FD6507B Q57083979-3206AAA2-AC09-49D3-B004-03E05A1CA653

P2860

Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia.

http://www.wikidata.org/entity/Q45875846

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Home-based factor infusion the ...... among males with haemophilia.

@en

Home-based factor infusion the ...... among males with haemophilia.

@nl

type

label

Home-based factor infusion the ...... among males with haemophilia.

@en

Home-based factor infusion the ...... among males with haemophilia.

@nl

prefLabel

Home-based factor infusion the ...... among males with haemophilia.

@en

Home-based factor infusion the ...... among males with haemophilia.

@nl

P1433

Q45875846-3CC702EA-6031-426F-9C44-817B493665B2

P1476

Q45875846-D63F4B20-207B-4816-B242-413739F13AA9

P2093

Q45875846-1E2E433F-C3C3-40D2-8500-0DF14B55A535

Q45875846-4856B29F-80F4-437C-B6F1-8E7B1AB463D1

Q45875846-8D3C8EA9-9E0E-4A68-B74F-433D1819AB8D

Q45875846-9B1F44C9-CCFA-4C24-A9DB-7A38B9FDE27E

Q45875846-9C0CF123-CE0E-4E57-8F16-485CDEC322B0

Q45875846-E7AB0CF3-5ABB-4BD2-91EF-77A8F0F89A0B

Q45875846-F4D8B16F-361B-4228-AD2C-B057D9C68227

P2860

Q45875846-15633DAF-6D94-44C3-9EEE-6A2753E464CF

Q45875846-31FF1DDA-0233-40FF-BB71-C3A1A39B0727

Q45875846-7323E40D-9B5E-454D-8363-19BD4E8490C1

Q45875846-73C1741E-1881-4459-9BE2-73C8EDF32AE5

Q45875846-837D7E9A-56C4-4065-B719-04B7641A6A14

Q45875846-8FA05236-7469-4A83-80AE-8942349A55E3

Q45875846-9D39CB9C-74C6-4A86-B170-25A50689D1BC

Q45875846-F58F7CC1-6017-497D-A9DB-A8A21B3918E4

Q45875846-F8BB529D-6DE5-4AD8-BF8A-46B516355C6A

P304

Q45875846-A389224F-478D-46B1-8C2C-71DFA3449277

P31

Q45875846-277E7558-F933-4AC3-B08F-A15D3311A5F7

P356

Q45875846-BDE19374-CD08-4607-8C6C-99E02FA08667

P433

Q45875846-A8559C9E-2214-40B7-8BA8-B235913615B1

P478

Q45875846-839BEFA7-779C-4788-BE65-63E4227DBD29

P577

Q45875846-E5D1E4FB-9219-482C-A7C7-20DA19D455B0

P698

Q45875846-32D30A97-B86A-48C0-9A60-AA5C3FE4B6CB

P921

Q45875846-49754D29-D6E7-417D-B31E-91CA606708E5

P356

J.1365-2516.2001.00484.X

P1433

P1476

Home-based factor infusion the ...... among males with haemophilia.

@en

P2093

B Evatt

http://www.w3.org/2001/XMLSchema#string

D Brettler

http://www.w3.org/2001/XMLSchema#string

H Huszti

http://www.w3.org/2001/XMLSchema#string

Hemophilia Surveillance System Project Investigators

http://www.w3.org/2001/XMLSchema#string

J Linden

http://www.w3.org/2001/XMLSchema#string

J M Soucie

http://www.w3.org/2001/XMLSchema#string

J Symons

http://www.w3.org/2001/XMLSchema#string

P2860

Social and psychological responses to home treatment of haemophilia.

Access of Medicaid recipients to outpatient care.

Home transfusion for patients with hemophilia A.

Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B.

Delayed access to health care: risk factors, reasons, and consequences.

Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.

Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program.

The impact of prophyactic treatment on children with severe haemophilia.

The uninsured. From dilemma to crisis.

P304

198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2516.2001.00484.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11260280

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization